Chicago Venture Partners
Chicago Venture Partners is a private equity investment firm based in Chicago, Illinois, founded in 1998. The firm specializes in growth and expansion investments, focusing on buyouts, PIPE transactions, and late-stage growth equity investments. It primarily targets the information technology, healthcare, and life sciences sectors. In addition to investing in private companies, Chicago Venture Partners also provides capital to publicly traded entities through private transactions and actively seeks strategic acquisitions for its wholly-owned and affiliated businesses.
Nemaura Medical Inc. is a medical technology company focused on developing and commercializing innovative diagnostic medical devices. The flagship product, sugarBEAT, is a non-invasive continuous glucose monitoring device designed for individuals with Type I and Type II diabetes, as well as for pre-diabetic screening. This device features a daily disposable adhesive skin patch linked to a rechargeable transmitter, providing glucose readings every five minutes through a compatible app for up to 24 hours. Nemaura Medical has also partnered with Healthimation, LLC, to offer a comprehensive medical program aimed at managing Type 2 diabetes, prediabetes, and general wellness through the Why WAIT app. Founded in 2009 and headquartered in New York, Nemaura Medical aims to revolutionize healthcare by integrating its advanced diagnostic technology with digital health platforms and artificial intelligence, positioning itself as a key player in the digital healthcare landscape.
Nemaura Medical Inc. is a medical technology company focused on developing and commercializing innovative diagnostic medical devices. The flagship product, sugarBEAT, is a non-invasive continuous glucose monitoring device designed for individuals with Type I and Type II diabetes, as well as for pre-diabetic screening. This device features a daily disposable adhesive skin patch linked to a rechargeable transmitter, providing glucose readings every five minutes through a compatible app for up to 24 hours. Nemaura Medical has also partnered with Healthimation, LLC, to offer a comprehensive medical program aimed at managing Type 2 diabetes, prediabetes, and general wellness through the Why WAIT app. Founded in 2009 and headquartered in New York, Nemaura Medical aims to revolutionize healthcare by integrating its advanced diagnostic technology with digital health platforms and artificial intelligence, positioning itself as a key player in the digital healthcare landscape.
GrowLife is a logistics and cultivation service provider based in Seattle, Washington. Founded in 1987, the company specializes in supplying hydroponic equipment, lighting, nutrients, media, and various cultivation supplies to both commercial and urban operations. In addition to its extensive range of cultivation products, GrowLife offers logistics and distribution services designed to help cultivation operations manage supply costs, optimize investments, track usage, and enhance workflow efficiency. The company also produces and supplies gourmet fresh mushrooms and functional mushroom products, along with mycological supplies. Through its comprehensive offerings, GrowLife supports responsible cultivation practices across the industry.
OncoVista Innovative Therapies, Inc. is a biopharmaceutical company based in San Antonio, Texas, founded in 2004. The company specializes in developing targeted anticancer therapies and diagnostic tests that utilize tumor-associated biomarkers. Its product pipeline includes Cordycepin (OVI-123), which is undergoing Phase I/II clinical trials for treating refractory TdT-positive leukemias, and L-Nucleoside Conjugates (OVI-117), currently in pre-clinical development for colon cancer. Additionally, OncoVista's subsidiary, AdnaGen AG, markets diagnostic kits in Europe for detecting circulating tumor cells in breast and colon cancers. The company has established collaborations with several prominent cancer research institutions, including the University of Texas Health Science Center and the Dana-Farber Cancer Institute. OncoVista is also exploring various platform technologies, including tubulin isotype-specific anti-mitotics, to advance its research and development efforts in cancer therapeutics.
IKANO Communications was founded over 10 years ago as a regional Internet service provider in the Intermountain West and since then has flourished to become the industry leader in private-label, wholesale, and retail Internet services. IKANO leverages its ISP platform to provide outstanding services at highly competitive prices. The company's rapid growth and excellence in the field have resulted in IKANO's ranking in the Inc. 500, Technology Fast 500, Inner City 100, Utah 100, and Call Center of the Year. The word "ikano" means "to enable" in the Greek language. Thus, IKANO is a leading enabler of Internet services and IP solutions. IKANO provides wholesale telco services for ISP's, turn key services for affinity groups, and retail services for IKANO owned brands. We leverage our relationships with telecommunications companies and CLEC's to help organizations that want to become more effective in acquiring new customers, communicating with customers and retaining customers through their e-business initiatives. As the official Data Networking Services Provider for the 2002 Olympic and Paralympic Winter Games, IKANO provided the data networking services and support for the 2002 Games.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.